R2.I.01/2022 - Investigador/a R2.I / Researcher R2.I (I-12)
Application Submission process
From: 11/03/2022 12:00 (UTC+01:00) Brussels, Copenhagen, Madrid, Paris
To: 07/02/2023 12:00 (UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Info:
Desarrollo de los objetivos establecidos en el proyecto “VALORIZATION OF A FIRST-IN-CLASS MCL-1 INHIBITOR”. Se trata de un proyecto traslacional que pretende progresar en las primeras etapas del desarrollo pre-clínico de una molécula con potencial antitumoral y facilitar la transferencia o explotación de los resultados. El candidato llevará a cabo ensayos de benchmarking en el laboratorio y participará en la redacción de patentes y contactos con empresas.
Se requiere por ello un candidato con espíritu emprendedor e innovador. Durante el desarrollo del proyecto se contribuirá a su capacitación a través de acciones de formación.
------------------------------------------
Development of the objectives established in the “VALORIZATION OF A FIRST-IN-CLASS MCL-1 INHIBITOR” project. This is a translational project that aims to progress in the early stages of preclinical development of a molecule with antitumor potential and to facilitate the transfer or exploitation of the results. The candidate will carry out benchmarking experiments in the laboratory and will participate in the drafting of patents and contacts with companies.
Therefore, a candidate with an entrepreneurial and innovative spirit is required. During the development of the project, the candidate could receive specific training on entrepreneurship.
Call Document
Resolución oferta de empleo R2.I.01/2022 I-12
For your safety, your session will be closed in
60
